Zaandam, the Netherlands, May 8, 2018 - Ahold Delhaize has repurchased 2,586,858 of Ahold Delhaize common shares in the period from April 30, 2018 up to and including May 4, 2018. The shares were repurchased at an average price of €19.64 per share for a total consideration of €50.8 million. These repurchases were made as part of the €2 billion share buyback program announced on November 8, 2017.
The total number of shares repurchased under this program to date is 35,808,009 common shares for a total consideration of €660.9 million.
Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/
This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.


Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



